These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 7076878)
1. Adults and adolescents with attention deficit disorder: clinical and behavioral responses to psychostimulants. Yellin AM; Hopwood JH; Greenberg LM J Clin Psychopharmacol; 1982 Apr; 2(2):133-6. PubMed ID: 7076878 [No Abstract] [Full Text] [Related]
2. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder. Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962 [TBL] [Abstract][Full Text] [Related]
3. Delta plots in the study of individual differences: new tools reveal response inhibition deficits in AD/Hd that are eliminated by methylphenidate treatment. Ridderinkhof KR; Scheres A; Oosterlaan J; Sergeant JA J Abnorm Psychol; 2005 May; 114(2):197-215. PubMed ID: 15869351 [TBL] [Abstract][Full Text] [Related]
4. Effects of methylphenidate on adolescents with a childhood history of attention deficit disorder: II. Information processing. Coons HW; Klorman R; Borgstedt AD J Am Acad Child Adolesc Psychiatry; 1987 May; 26(3):368-74. PubMed ID: 3298202 [No Abstract] [Full Text] [Related]
5. Methylphenidate compared with behavioral self-control in attention deficit disorder: preliminary report. Anderson EE; Clement PW; Oettinger L J Dev Behav Pediatr; 1981 Dec; 2(4):137-41. PubMed ID: 7320203 [TBL] [Abstract][Full Text] [Related]
6. Attentional capacity, a probe ERP study: differences between children with attention-deficit hyperactivity disorder and normal control children and effects of methylphenidate. Jonkman LM; Kemner C; Verbaten MN; Van Engeland H; Camfferman G; Buitelaar JK; Koelega HS Psychophysiology; 2000 May; 37(3):334-46. PubMed ID: 10860411 [TBL] [Abstract][Full Text] [Related]
7. Effect of methylphenidate on Stroop Color-Word task performance in children with attention deficit hyperactivity disorder. Langleben DD; Monterosso J; Elman I; Ash B; Krikorian G; Austin G Psychiatry Res; 2006 Mar; 141(3):315-20. PubMed ID: 16516306 [TBL] [Abstract][Full Text] [Related]
8. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder. Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289 [TBL] [Abstract][Full Text] [Related]
9. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study. Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731 [TBL] [Abstract][Full Text] [Related]
10. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains. Rhodes SM; Coghill DR; Matthews K J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758 [TBL] [Abstract][Full Text] [Related]
11. An objective measure of methylphenidate response: clinical use of the MCA. Greenberg LM Psychopharmacol Bull; 1987; 23(2):279-82. PubMed ID: 3615775 [No Abstract] [Full Text] [Related]
13. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. Bush G; Spencer TJ; Holmes J; Shin LM; Valera EM; Seidman LJ; Makris N; Surman C; Aleardi M; Mick E; Biederman J Arch Gen Psychiatry; 2008 Jan; 65(1):102-14. PubMed ID: 18180434 [TBL] [Abstract][Full Text] [Related]
14. Perceptual and response interference in children with attention-deficit hyperactivity disorder, and the effects of methylphenidate. Jonkman LM; Kemner C; Verbaten MN; Van Engeland H; Kenemans JL; Camfferman G; Buitelaar JK; Koelega HS Psychophysiology; 1999 Jul; 36(4):419-29. PubMed ID: 10432791 [TBL] [Abstract][Full Text] [Related]
15. Executive functions and methylphenidate response in subtypes of attention-deficit/hyperactivity disorder. O'Driscoll GA; Dépatie L; Holahan AL; Savion-Lemieux T; Barr RG; Jolicoeur C; Douglas VI Biol Psychiatry; 2005 Jun; 57(11):1452-60. PubMed ID: 15950020 [TBL] [Abstract][Full Text] [Related]
16. The effect of methylphenidate on postural stability under single and dual task conditions in children with attention deficit hyperactivity disorder - a double blind randomized control trial. Jacobi-Polishook T; Shorer Z; Melzer I J Neurol Sci; 2009 May; 280(1-2):15-21. PubMed ID: 19217632 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder. Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131 [TBL] [Abstract][Full Text] [Related]
18. Methylphenidate HCl: therapy for attention deficit hyperactivity disorder. Capp PK; Pearl PL; Conlon C Expert Rev Neurother; 2005 May; 5(3):325-31. PubMed ID: 15938665 [TBL] [Abstract][Full Text] [Related]
19. Sustained attention in boys with attention deficit disorder and the effect of methylphenidate. Brown RT; Wynne ME Pediatr Nurs; 1984; 10(1):35-9. PubMed ID: 6560384 [No Abstract] [Full Text] [Related]
20. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder. Fone KC; Nutt DJ Curr Opin Pharmacol; 2005 Feb; 5(1):87-93. PubMed ID: 15661631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]